I've been tracking hsCRP since before starting semaglutide and I think this is one of the most underappreciated benefits of GLP-1 therapy. Nobody talks about inflammation — it's all weight and A1C — but systemic inflammation is a major driver of cardiovascular disease, cancer, and neurodegeneration.

My hsCRP timeline:

From high risk to low risk in 12 months. An 8.4 to 0.8 drop is a 90% reduction in systemic inflammation.

M/51, 5'10". Also doing: walking 40 min/day, Mediterranean-style diet, cut alcohol to 1-2 drinks/week, sleep 7-8 hours.

I want to note: the SELECT cardiovascular outcomes trial showed that the benefit of semaglutide for reducing heart attacks and strokes was GREATER than what weight loss alone would predict, and many researchers believe the anti-inflammatory effects are a major reason why.

This is an important thread. hsCRP is one of the best validated biomarkers for cardiovascular risk, and the magnitude of reduction you're showing is clinically meaningful.

Some context on the mechanisms: GLP-1 receptor agonists appear to have direct anti-inflammatory effects beyond what's mediated by weight loss:

1. Reduced macrophage infiltration of adipose tissue
2. Decreased hepatic production of inflammatory cytokines (IL-6, TNF-alpha)
3. Improved endothelial function (which is both a cause and consequence of inflammation)
4. Reduced visceral fat, which is more metabolically active and pro-inflammatory than subcutaneous fat

The SELECT trial you referenced showed a 20% reduction in major adverse cardiovascular events (MACE). Post-hoc analyses suggested that hsCRP reduction was an independent mediator of that benefit — meaning some of the cardiovascular protection came from inflammation reduction rather than weight loss per se.

My story mirrors yours. hsCRP went from 6.2 to 1.1 over 8 months on tirzepatide. My rheumatologist (I have mild psoriatic arthritis) actually noticed improvement in my joint inflammation markers too — ESR dropped from 28 to 12.

I hadn't connected it to the tirzepatide until my rheumatologist pointed out that GLP-1 medications have systemic anti-inflammatory properties. She said some researchers are even exploring them for inflammatory conditions independent of weight loss.

I just got my hsCRP tested for the first time at 4.7 mg/L. I'm 3 months into semaglutide. Is there a standard recommendation for how often to recheck?

I test every 3 months which is probably overkill but I'm a data nerd. For most people, checking at baseline and then every 6 months is reasonable. The one caveat is that hsCRP is an acute phase reactant — it spikes temporarily with infections, injuries, or dental work. So if you get a random high reading, don't panic — retest in 2-3 weeks. My 4.9 at month 3 might have been slightly elevated because I had a mild cold the week before the blood draw.

Also make sure your lab is ordering hsCRP (high-sensitivity) and not regular CRP. Regular CRP has a much higher detection limit and isn't useful for cardiovascular risk stratification.